BIDEA

company

About

BIDEA develops point-of-care in-vitro diagnostic devices for the early detection of endometrial cancer.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Health Care,Medical Device,Women's
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

BIDEA offers tests that will not only impact the quality of life of patients but can also reduce costs to hospitals, health insurance companies, and government agencies. Their proposed screening technology is expected to help gynaecologists in hospitals and in private practices provide a complete diagnosis in less time, reducing the number of visits and endometrial cancer incidence through early detection, especially in women over the age of 50.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$225K
BIDEA has raised a total of $225K in funding over 2 rounds. Their latest funding was raised on Dec 29, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 29, 2017 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
BIDEA is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant